SHAREHOLDER ALERT: FULC ADDYY SPR: The Law Offices of Vincent Wong Reminds Investors of Important Class Action DeadlinesAccesswire • 05/31/23
INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Fulcrum Therapeutics, Inc. with Losses of $100,000 to Contact the FirmAccesswire • 05/30/23
FULCRUM THERAPEUTICS, INC. (NASDAQ: FULC) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Fulcrum Therapeutics, Inc.PRNewsWire • 05/30/23
IMPORTANT DEADLINE REMINDER: The Schall Law Firm Encourages Investors in Fulcrum Therapeutics, Inc. with Losses of $100,000 to Contact the FirmAccesswire • 05/28/23
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Fulcrum Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - FULCPRNewsWire • 05/27/23
Fulcrum Therapeutics: FSHD Steadily Advancing In Phase 3, Optionality With SCDSeeking Alpha • 05/24/23
ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Fulcrum Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FULCPRNewsWire • 05/21/23
INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Fulcrum Therapeutics, Inc. with Losses of $100,000 to Contact the FirmAccesswire • 05/19/23
FULCRUM THERAPEUTICS, INC. (NASDAQ: FULC) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Fulcrum Therapeutics, Inc. (NASDAQ: FULC)PRNewsWire • 05/15/23
Fulcrum Therapeutics, Inc. (FULC) Reports Q1 Loss, Misses Revenue EstimatesZacks Investment Research • 05/15/23
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for the First Quarter 2023GlobeNewsWire • 05/15/23
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Fulcrum Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - FULCPRNewsWire • 05/12/23
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Fulcrum Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – FULCBusiness Wire • 05/11/23
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Fulcrum Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 27, 2023 - (NASDAQ: FULC)PRNewsWire • 05/10/23
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fulcrum Therapeutics, Inc. (FULC)Business Wire • 05/09/23
Fulcrum Therapeutics, Inc. (FULC) Class Action Notice: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Class Action Against Fulcrum Therapeutics, Inc.Business Wire • 05/08/23
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fulcrum Therapeutics, Inc. (FULC)Business Wire • 05/08/23
FULC EQUITY ALERT: ROSEN, A LEADING LAW FIRM, Encourages Fulcrum Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FULCPRNewsWire • 05/03/23
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Fulcrum Therapeutics, Inc. (FULC) InvestorsBusiness Wire • 05/03/23
FULC EQUITY ALERT: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Fulcrum Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – FULCBusiness Wire • 05/02/23
Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Fulcrum Therapeutics, Inc. (FULC) Investors of Class Action and to Actively ParticipatePRNewsWire • 05/02/23
FULCRUM THERAPEUTICS, INC. (NASDAQ: FULC) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Fulcrum Therapeutics, Inc. (NASDAQ: FULC)PRNewsWire • 05/02/23
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Fulcrum Therapeutics, Inc. (FULC) InvestorsBusiness Wire • 05/02/23
